These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 6130430)

  • 41. K receptor activities of the three opioid peptide families.
    Rezvani A; Höllt V; Way EL
    Life Sci; 1983; 33 Suppl 1():271-4. PubMed ID: 6319875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
    Dray A; Nunan L; Wire W
    J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary.
    Seizinger BR; Grimm C; Höllt V; Herz A
    J Neurochem; 1984 Feb; 42(2):447-57. PubMed ID: 6141221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motility effects of opioid peptides in dog intestine.
    Burks TF; Hirning LD; Galligan JJ; Davis TP
    Life Sci; 1982 Nov 15-22; 31(20-21):2237-40. PubMed ID: 6298519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opioid activity of enkephalin analogues containing the kyotorphin-related structure in the N-terminus.
    Amano H; Morimoto Y; Kaneko S; Takagi H
    Neuropharmacology; 1984 Apr; 23(4):395-400. PubMed ID: 6328351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase in potencies of opioid peptides after peptidase inhibition.
    McKnight AT; Corbett AD; Kosterlitz HW
    Eur J Pharmacol; 1983 Jan; 86(3-4):393-402. PubMed ID: 6299758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Illes P
    J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of receptor theory provides further evidence for the existence of the epsilon-opioid receptor in rat vas deferens.
    Garzón J; Schulz R; Herz A
    Neuropeptides; 1984 Dec; 5(1-3):101-4. PubMed ID: 6099473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids.
    Waterman SA; Costa M; Tonini M
    Br J Pharmacol; 1992 Aug; 106(4):1004-10. PubMed ID: 1356564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release.
    Nikolarakis KE; Almeida OF; Yassouridis A; Herz A
    Neuroscience; 1989; 31(1):269-73. PubMed ID: 2570378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
    Ho CL; Li CH
    Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats.
    Tseng LF; Towell JF; Fujimoto JM
    J Pharmacol Exp Ther; 1986 Apr; 237(1):65-74. PubMed ID: 2420969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice.
    Sánchez-Blázquez P; Garzón J
    Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.